Dr Iresh Shetty, Consultant Cardiac Surgeon, KMC Hospital Mangalore Ischemic Heart disease is considered to be the leading cause of death not only in India but across the world. Previously thought to ...
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.